… collaboration with Jazz Pharmaceuticals focused on evaluating … development of genetic medicines made by … drug combination called “PIKTOR,” alongside the chemotherapy paclitaxel as a treatment … Francisco-based biotech says its drug specifically targets …

… phase 3 randomized clinical trial. JAMA Oncol. 2018; … of triple-drug combination of albumin-bound paclitaxel, anlotinib and … analysis of 2 single-arm trials. Medicine. 2024;103(27):e38459 … non-small cell lung cancer treatment. Pharmaceuticals. 2025;18(4):585 …

… ) as part of a complete treatment regimen for early breast cancer … in combination with trastuzumab and paclitaxel following 4 cycles of dose … ;/www.fda.gov/drugs/;resources-information-approved-drugs/fda-approves-new-interchangeable …

… continued innovation is transforming treatment across all cancer … the future of precision medicine, novel therapeutic combinations … combination of Abraxane (nab-paclitaxel), relacorilant plus Avastin ( … available for clinical trials moving forward. In …

… FDA fully approved the combination of pembrolizumab and lenvatinib for treatment … 775/Study 309 trial (NCT03517449).3 The … , open-label, multicenter trial that aimed to evaluate … of chemotherapy (doxorubicin or paclitaxel). The investigational regimen …

… clinical trials, nausea … 6 and paclitaxel every 3 … trial of trimethobenzamide to control nausea and vomiting during initiation and continued treatment … drug-safety-and-availability/fda-warns-about-serious-breathing-problems-seizure-and-nerve-pain-medicines …

… the New Drug Application (NDA) for the treatment of children … with FDA, we plan to initiate a Phase 3 trial of … weeks in combination with weekly paclitaxel is generally well-tolerated, … class potential to address unmet medical needs. Ascendis is headquartered …

… trial landscape includes several promising drugs … clinical trials, visit @ KRAS Inhibitors Treatment  … only FDA-approved medicine for this … Pharmaceuticals, Surgimab, Numab Therapeutics, SOTIO Biotech, Amgen, Sichuan Baili Pharmaceutical, Qilu Pharmaceutical …

… data from a phase 1b trial (NCT05911217) presented during … ’s National Medical Products Administration accepted a new drug application (NDA … 1 to 3, and nab-paclitaxel (Abraxane) at 100 mg … The most common any-grade treatment-emergent adverse effects (TEAEs) …

… system for chemotherapeutic drugs, gene drugs, or immunostimulants. … of Medicinal Plant Development, Peking Union Medical College … al. Successful treatment with carboplatin and paclitaxel in melanoma … AIEgens and paclitaxel. Front Bioeng Biotechnol. 2023;11 …